Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307218

Chief Financial Officer acquired 356 shares (grant or award)

  • Chief Financial Officer gave up 118 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mokari Atabak · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Grant or award : show line 1 in the form +178 $79.78 $14,201 14,499 D
2025-12-01 Grant or award : show line 2 in the form +178 14,677 D
2025-12-02 Shares withheld for taxes : show line 3 in the form −118 $79.78 $9,414 14,559 D
Loading xslF345X05/ownership.xml…